1. Home
  2. News
  3. Immutep Ltd
  4. Publication of Abstracts for ASCO 2023 Annual Meeting
More Immutep Ltd news
Immutep LtdASX: IMM

Publication of Abstracts for ASCO 2023 Annual Meeting

May 25, 2023 at 10:45 PM EDT · Issued by Immutep Ltd

Filed with ASX · May 25, 2023 at 10:45 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/publication-of-abstracts-for-asco-2023-annual-meeting

Immutep Ltd on 6ix

Story so far

  • Immutep to announce new TACTI-002 data at ASCO 2023Apr 27, 2023
  • Abstracts accepted for Presentation at SITC 2022Oct 6, 2022
  • Immutep announces publication of ASCO 2022 abstractsMay 27, 2022

Earlier from Immutep

  • 1st patient dosed in AIPAC-003 ph2/3 breast cancer trialMay 24, 2023
  • Promising New Data in 1st line NSCLC from INSIGHT-003 TrialMay 23, 2023
  • Excellent initial Overall Survival Benefit in 1st line NSCLCMay 16, 2023
  • FDA supportive of Efti registrational trial in lung cancerMay 15, 2023
  • Approval to start Efti & Bavencio trial in urothelial cancerApr 30, 2023

Later from Immutep

  • Charles River Laboratories to run IMP761 Toxicology StudyMay 28, 2023
  • A$80 million fully underwritten equity raisingMay 30, 2023
  • Immutep granted US patent for IMP761 agonist LAG-3 antibodyJun 20, 2023
  • US patent granted for Efti with PD-1 pathway inhibitorJun 27, 2023
  • 1st Patient Dosed in Phase 2 Soft Tissue Sarcoma TrialJul 27, 2023
All Immutep news releases↗

Follow Immutep into a list and get an email when it puts out news.

Follow Immutep
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer